GENTILE, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 11
EU - Europa 6
NA - Nord America 1
Totale 18
Nazione #
IT - Italia 6
KR - Corea 6
SG - Singapore 4
CN - Cina 1
US - Stati Uniti d'America 1
Totale 18
Città #
Seoul 6
Singapore 3
Bitonto 2
Forest City 1
Guangzhou 1
Totale 13
Nome #
Una piattaforma array CGH custom per l'identificazione di CNV in pazienti affetti da Sindromi Neurocutanee ed altri disordini neurologici: validazione della regione d'interesse per la Neurofibromatosi di tipo 1 4
Cx26 partial loss causes accelerated presbycusis by redox imbalance and dysregulation of Nfr2 pathway 2
A neurocutaneous phenotype with paired hypo- and hyperpigmented macules, microcephaly and stunted growth as prominent features 2
Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/-/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611 1
Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions 1
A genomic screening platform highlighting differences and overlaps in neurodegenerative diseases 1
Scienze "omiche" e biologia dei sistemi complessi: applicazioni in neurologia pediatrica 1
miRNA and mRNA Profiling Links Connexin Deficiency to Deafness via Early Oxidative Damage in the Mouse Stria Vascularis 1
CXCL12 (chemokine (C-X-C motif) ligand 12) 1
RAPID IDENTIFICATION OF PATHOGENIC VARIANTS IN NEUROFIBROMATOSIS DISEASE BY GENE-PANEL SEQUENCING. 1
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases 1
ALS and CHARGE syndrome: a clinical and genetic study 1
Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development 1
Totale 18
Categoria #
all - tutte 377
article - articoli 279
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202410 0 0 0 0 0 0 0 0 2 0 7 1
2024/20258 2 6 0 0 0 0 0 0 0 0 0 0
Totale 18